SAN DIEGO--(BUSINESS WIRE)--Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) today announced that it will conduct a conference call and live webcast on May 13, 2008 at 2:00 p.m. EDT (11:00 a.m. PDT) to review its clinical development programs and first quarter 2008 financial results. The Company filed today its Form 10-Q with the Securities and Exchange Commission for the first quarter ended March 31, 2008, and will issue prior to the market opening on May 13th a news release reviewing its clinical development programs and first quarter financial results.
